Philip Morris International Inc. (PMI) to Host Webcast of 2022 Fourth-Quarter and Full-Year Results
02 Februar 2023 - 07:02PM
Business Wire
Regulatory News:
Philip Morris International Inc. (NYSE: PM) will host a live
audio webcast on www.pmi.com/2022Q4earnings on Thursday, February
9, 2023, at 9:00 a.m. ET, to discuss its 2022 Fourth-Quarter and
Full-Year results, which will be issued at approximately 7:00 a.m.
ET the same day.
During the webcast, Jacek Olczak, Chief Executive Officer, and
Emmanuel Babeau, Chief Financial Officer, will discuss PMI’s 2022
results and 2023 outlook, and answer questions from the investment
community and news media. The webcast will be in a listen-only
mode.
The audio webcast may also be accessed on iOS or Android devices
by downloading PMI’s free Investor Relations Mobile Application on
www.pmi.com/irapp.
An archived copy of the webcast will be available until 5:00
p.m. ET on Friday, March 10, 2023, on
www.pmi.com/2022Q4earnings.
Slides and script will also be available on
www.pmi.com/2022Q4earnings.
Philip Morris International: Delivering a Smoke-Free
Future
Philip Morris International (PMI) is a leading international
tobacco company working to deliver a smoke-free future and evolving
its portfolio for the long term to include products outside of the
tobacco and nicotine sector. The company’s current product
portfolio primarily consists of cigarettes and smoke-free products,
including heat-not-burn, vapor and oral nicotine products, which
are sold in markets outside the U.S. Since 2008, PMI has invested
more than USD 9 billion to develop, scientifically substantiate and
commercialize innovative smoke-free products for adults who would
otherwise continue to smoke, with the goal of completely ending the
sale of cigarettes. This includes the building of world-class
scientific assessment capabilities, notably in the areas of
pre-clinical systems toxicology, clinical and behavioral research,
as well as post-market studies. The U.S. Food and Drug
Administration (FDA) has authorized the marketing of versions of
PMI’s IQOS Platform 1 devices and consumables as a Modified Risk
Tobacco Products (MRTPs), finding that an exposure modification
orders for these products are appropriate to promote the public
health. As of September 30, 2022, excluding Russia and Ukraine,
PMI's smoke-free products are available for sale in 70 markets, and
PMI estimates that approximately 13.5 million adults around the
world had already switched to IQOS and stopped smoking. With a
strong foundation and significant expertise in life sciences, in
February 2021, PMI announced its ambition to expand into wellness
and healthcare areas and deliver innovative products and solutions
that aim to address unmet consumer and patient needs. For more
information, please visit www.pmi.com and www.pmiscience.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230202005587/en/
Philip Morris International Investor Relations: Stamford,
CT: +1 (203) 904 2410 Lausanne: +41 (0)58 242 4666 Email:
InvestorRelations@pmi.com Media: David Fraser Lausanne: +41 (0)58
242 4500 Email: David.Fraser@pmi.com
Philip Morris (NYSE:PM)
Historical Stock Chart
Von Mär 2023 bis Mär 2023
Philip Morris (NYSE:PM)
Historical Stock Chart
Von Mär 2022 bis Mär 2023